Taysha Gene Therapies, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $343.3M
Liabilities Breakdown FY2025
Total Liabilities: $96.4M
Asset Breakdown
Total Assets: $343.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $319.8M | 93.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $6.7M | 2.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $16.8M | 4.9% |
Liabilities Breakdown
Total Liabilities: $96.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $6.3M | 6.5% |
| Long-Term Debt | $50.1M | 52.0% |
| Other Liabilities | $40.0M | 41.5% |